Description
Irinotecan 100mg Vial: Key Information
What is Irinotecan ?
IRINOTECAN 100MG VIAL 1S treats various cancers, most commonly colorectal cancer. This injectable chemotherapy medication belongs to a class of drugs called topoisomerase inhibitors. It interferes with DNA replication in cancer cells, slowing their growth and leading to cell death. Healthcare providers often combine Irinotecan with other chemotherapy drugs for enhanced effectiveness.
How Irinotecan Works
Irinotecan inhibits the enzyme topoisomerase I, which cancer cells need for DNA replication and repair. By blocking this enzyme, Irinotecan prevents cancer cells from dividing and multiplying. As a result, it slows cancer progression and reduces tumor growth. This targeted action makes it effective, particularly for colorectal cancer that has spread or cannot be surgically removed.
Benefits of Irinotecan
- Effective Cancer Treatment: Irinotecan slows the progression of cancer, especially in advanced or metastatic colorectal cancer.
- Combination Therapy: Irinotecan works well in combination with other chemotherapy agents, increasing the chances of controlling the disease.
- Inhibits Cancer Cell Growth: By targeting topoisomerase I, Irinotecan blocks the replication of cancer cells, shrinking tumors.
Dosage and Administration
Healthcare professionals administer Irinotecan through an intravenous infusion. The dosage and frequency depend on the type of cancer, the patient’s body size, and their response to treatment. Typically, the treatment occurs in cycles with rest periods between sessions to allow recovery.
Side Effects and Precautions
IRINOTECAN 100MG VIAL 1S can cause side effects such as nausea, vomiting, diarrhea, and hair loss. More serious effects include a decrease in white blood cells, which raises the risk of infections, and severe diarrhea that may need immediate medical attention. Always inform your healthcare provider of any pre-existing conditions or medications to ensure safe and effective treatment.
